Cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium
C21H24F3N2O2+ — CID 8906875
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium
Cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium (PubChem CID 8906875) has the molecular formula C21H24F3N2O2+ and a molecular weight of 393.43 g/mol. Its IUPAC name is cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium.
Molecular Properties
| Compound Name | Cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium |
|---|---|
| PubChem CID | 8906875 |
| Molecular Formula | C21H24F3N2O2+ |
| Molecular Weight | 393.43 g/mol |
| Exact Mass | 393.18 |
| IUPAC Name | cyclopropyl-[2-[2-[4-(difluoromethoxy)phenyl]ethylamino]-2-oxoethyl]-[(4-fluorophenyl)methyl]azanium |
| SMILES | O=C(C[NH+](Cc1ccc(F)cc1)C1CC1)NCCc1ccc(OC(F)F)cc1 |
| InChI | InChI=1S/C21H23F3N2O2/c22-17-5-1-16(2-6-17)13-26(18-7-8-18)14-20(27)25-12-11-15-3-9-19(10-4-15)28-21(23)24/h1-6,9-10,18,21H,7-8,11-14H2,(H,25,27)/p+1 |
| InChIKey | VOZVPQQCSSONOS-UHFFFAOYSA-O |
| XLogP | 2.33 |
| TPSA | 42.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 393.43 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 8906875 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.